基于傾向性評(píng)分匹配的疾病診斷相關(guān)分組支付方式下江蘇省某兒童醫(yī)院再生障礙性貧血患者住院費(fèi)用的控費(fèi)效果
首發(fā)時(shí)間:2025-10-17
沈林羽(1999-),女,主要研究方向:醫(yī)療保險(xiǎn)和衛(wèi)生管理
馬亞娜 1馬亞娜(1968-),女,副教授、碩導(dǎo),主要研究方向:社區(qū)健康管理.
摘要:目的評(píng)估疾病診斷相關(guān)分組付費(fèi)改革對(duì)江蘇省某三甲兒童醫(yī)院2021年1月-2023年12月收治的再生障礙性貧血患者住院費(fèi)用的控費(fèi)效果,并分析疾病診斷相關(guān)分組編碼對(duì)醫(yī)保外自付比例的影響。方法收集符合條件的809例患者數(shù)據(jù),其中疾病診斷相關(guān)分組付費(fèi)組112例,傳統(tǒng)付費(fèi)組697例。本研究創(chuàng)新性地將傾向性評(píng)分匹配法應(yīng)用于血液系統(tǒng)非手術(shù)慢性病的疾病診斷相關(guān)分組控費(fèi)效果評(píng)估,平衡兩組基線差異后,借助Wilcoxon秩和檢驗(yàn)對(duì)比組間費(fèi)用差異;首次采用Beta回歸模型深入分析不同疾病診斷相關(guān)分組編碼對(duì)患者自付比例的異質(zhì)性影響,以醫(yī)保外自付比例為因變量,分組編碼為自變量。結(jié)果經(jīng)傾向性評(píng)分匹配后納入336例患者(疾病診斷相關(guān)分組付費(fèi)組112例,傳統(tǒng)付費(fèi)組224例),疾病診斷相關(guān)分組付費(fèi)組醫(yī)療總費(fèi)用中位數(shù)為7013.54元,顯著低于傳統(tǒng)付費(fèi)組的11481.16元(P<0.05);西藥費(fèi)、化驗(yàn)費(fèi)等明細(xì)費(fèi)用組間差異顯著(P<0.05)。Beta回歸顯示,不同疾病診斷相關(guān)分組編碼對(duì)醫(yī)保外自付比例影響存在顯著異質(zhì)性(P<0.05),QS35分組的邊際效應(yīng)最高(0.2206),QQY分組次之(0.3757)。結(jié)論本研究填補(bǔ)了疾病診斷相關(guān)分組付費(fèi)改革在兒童血液系統(tǒng)疾病領(lǐng)域的研究空白,證實(shí)疾病診斷相關(guān)分組付費(fèi)對(duì)再生障礙性貧血患者住院費(fèi)用有顯著控費(fèi)效果,但不同分組自付比例的異質(zhì)性提示需優(yōu)化分組策略,為兒童專科醫(yī)院精準(zhǔn)支付政策制定提供了實(shí)證依據(jù)。
關(guān)鍵詞: 疾病診斷相關(guān)分組付費(fèi)改革 再生障礙性貧血 住院費(fèi)用 傾向性評(píng)分匹配 Beta回歸 醫(yī)療保障。
For information in English, please click here
The Cost Control Effect of Hospitalization Expenses for Aplastic Anemia Patients in a Children\'s Hospital in Jiangsu Province under the DRG Payment Method Based on PSM
沈林羽(1999-),女,主要研究方向:醫(yī)療保險(xiǎn)和衛(wèi)生管理
Ma YaNa 1馬亞娜(1968-),女,副教授、碩導(dǎo),主要研究方向:社區(qū)健康管理.
Abstract:Objective To evaluate the cost control effect of the Diagnosis-Related Groups (DRG) payment reform on the hospitalization costs of aplastic anemia patients admitted to a tertiary hospital in Jiangsu Province from January 2021 to December 2023, and to analyze the impact of DRG group coding on out-of-pocket expenses outside of health insurance. Methods Data from 809 eligible patients were collected, including 112 in the DRG group and 697 in the non-DRG group. This study innovatively applied propensity score matching (PSM) to evaluate the cost control effect of DRG on non-surgical chronic hematological diseases, , balancing baseline differences between the two groups, and Wilcoxon rank sum test was employed to compare cost differences; For the first time, a Beta regression model was used to deeply analyze the heterogeneous impact of different DRG group codes on patients\' out-of-pocket ratios, with out-of-pocket expenses as the dependent variable and DRG group coding as the independent variable. Results After PSM, 336 patients were included (112 in the DRG group and 224 in the non-DRG group). The median total medical expense in the DRG group was 7013.54 yuan, significantly lower than the 11481.16 yuan in the non-DRG group (P<0.05); there were significant differences in detailed expenses such as Western medicine costs and laboratory fees between the two groups (P<0.05). Beta regression showed that different DRG group codes had a significant impact on out-of-pocket expenses outside of health insurance (P<0.05), with the highest marginal effect observed in the QS35 group (0.2206). Conclusion This study fills the research gap of DRG payment reform in pediatric hematological diseases, confirming that DRG has a significant cost control effect on hospitalization costs of aplastic anemia patients. However, the heterogeneity of out-of-pocket ratios among different DRG groups suggests the need for optimized grouping strategies, providing empirical evidence for formulating precise DRG payment policies in children\'s specialty hospitals.
Keywords: DRG payment reform aplastic anemia hospitalization costs propensity score matching Beta regression Medical coverage
引用

No.****
動(dòng)態(tài)公開(kāi)評(píng)議
共計(jì)0人參與
勘誤表
基于傾向性評(píng)分匹配的疾病診斷相關(guān)分組支付方式下江蘇省某兒童醫(yī)院再生障礙性貧血患者住院費(fèi)用的控費(fèi)效果
評(píng)論
全部評(píng)論